Management of pulmonary hypertension due to heart failure with preserved ejection fraction.

about

Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction

P2860

Q28073079-85438480-30FF-418D-8FEF-920A44F6BE17

P2860

Management of pulmonary hypertension due to heart failure with preserved ejection fraction.

Item

http://www.wikidata.org/entity/Q38260650

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Management of pulmonary hypert ...... h preserved ejection fraction.

@en

type

Item

label

Management of pulmonary hypert ...... h preserved ejection fraction.

@en

prefLabel

Management of pulmonary hypert ...... h preserved ejection fraction.

@en

P1476

Management of pulmonary hypert ...... h preserved ejection fraction.

@en

P2093

Claire Walter

http://www.w3.org/2001/XMLSchema#string

George Sokos

http://www.w3.org/2001/XMLSchema#string

Megan M Clarke

http://www.w3.org/2001/XMLSchema#string

Raymond L Benza

http://www.w3.org/2001/XMLSchema#string

Richa Agarwal

http://www.w3.org/2001/XMLSchema#string

Ryan J Tedford

http://www.w3.org/2001/XMLSchema#string

Srinivas Murali

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

Pulmonary hypertension in heart failure preserved ejection fraction: prevalence, pathophysiology, and clinical perspectives

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Effects of endothelin a receptor blockade on endothelial function in patients with chronic heart failure.

HFSA 2010 Comprehensive Heart Failure Practice Guideline.

Definitions and diagnosis of pulmonary hypertension.

Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study.

Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials.

Irbesartan in patients with heart failure and preserved ejection fraction.

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

P2888

s11906-014-0501-5

P304

501

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11906-014-0501-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Manreet Kanwar

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1008217686

http://www.w3.org/2001/XMLSchema#string

P698

25320018

http://www.w3.org/2001/XMLSchema#string

P921

heart failure

Management of pulmonary hypertension due to heart failure with preserved ejection fraction.

about

P2860

P2860

Management of pulmonary hypertension due to heart failure with preserved ejection fraction.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921